相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advanced HIV: diagnosis, treatment, and prevention
Sandeep Prabhu et al.
LANCET HIV (2019)
Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program
Pengtao Liu et al.
SCIENTIFIC REPORTS (2018)
Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa ( PIONA): A Randomized Controlled Trial
Sanne Jespersen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Adam Trickey et al.
LANCET HIV (2017)
The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis
Haochu Li et al.
AIDS AND BEHAVIOR (2017)
The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea
Mina Park et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia
Demewoz Haile et al.
PLOS ONE (2016)
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET HIV (2016)
Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women
Deborah Cohan et al.
AIDS (2015)
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230
Nagalingeswaran Kumarasamy et al.
CLINICAL INFECTIOUS DISEASES (2015)
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
Paula M. Luz et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection
Xianmin Meng et al.
PLOS ONE (2015)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel
Huldrych F. Guenthard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala
Eva Laker et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Resistance at Virological Failure Using Boosted Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors As First-Line Antiretroviral Therapy-Implications for Sustained Efficacy of ART in Resource-Limited Settings
Andrew Hill et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review
Suelen Jorge Souza et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2013)
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
Ravindra K. Gupta et al.
LANCET (2012)
A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks
Joseph Gathe et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks
Jean-Michel Molina et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
F García et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
分享论文
